Creative funding options for biotechs

3:30 PM - 4:30 PM (EDT), Monday, June 5, 2023 ・ Session Room 209
We will dive deep into the challenges faced by biotech companies in securing funding, particularly in the early stages of development. Our panelists will share their insights on various funding options, including traditional venture capital, mergers and acquisitions, crowdfunding, grants, and other non-traditional funding sources.

We will also explore the advantages and disadvantages of each funding option and discuss best practices for developing a successful funding strategy. Whether you are an entrepreneur, investor, or industry professional, learn about all the options so you can continue to focus on the science that may help patients.
Sponsored By
editor in chief
President and CEO
BlueRock Therapeutics
SVP and Head of New Platforms, Cardiovascular and Immunology
Bayer Pharmaceuticals
Managing Director, Entrepreneurship
University of California San Francisco (UCSF)
Panacea Venture